PTAFR and non-small cell lung carcinoma: In addition, univariate and multivariate analyses showed that abundance of SP, expression of PAFR, patient age, and tumor stage of NSCLC were significantly associated with disease-specific survival time of the patients (All p < 0.05) (Tables S2 and S3).